Hundreds of cases of blindness are among the 19,916 reports of “eye disorders” to the World Health Organization’s European drug monitoring agency following injection of experimental COVID-19 vaccines.
The nearly 20,000 eye disorders reported to VigiBase, a database for the WHO maintained by the Uppsala Monitoring Centre(UMC) in Uppsalla, Sweden, include:
- Eye pain (4616)
- Blurred vision (3839)
- Photophobia or light intolerance (1808)
- Visual impairment (1625)
- Eye swelling (1162)
- Ocular hyperaemia or red eyes (788)
- Eye irritation (768)
- Itchy eyes or eye pruritus (731)
- Watery eyes or increased lacrimation (653)
- Double vision or diplopia (559)
- Eye strain or asthenopia (459)
- Dry eye (400)
- Swelling around the eye or periorbital swelling (366)
- Swelling of eyelid (360)
- Flashes of light in the field of vision or photopsia (358)
- Blindness (303)
- Eyelid oedema (298)
- Eye or ocular discomfort (273)
- Conjunctival haemorrhage or breakage of a small eye vessel (236)
- Blepharospasm or abnormal contraction of an eye muscle(223)
- Vitreous floaters (192)
- Periorbital oedema (171)
- Eye haemorrhage (169)
More than half of the eye disorders (10,667) were also reported to the U.K.’s Yellow Card adverse event reporting system.
No comments:
Post a Comment